SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-16-000164
Filing Date
2016-04-12
Accepted
2016-04-12 16:03:27
Documents
11
Period of Report
2016-04-12
Effectiveness Date
2016-04-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A lgnd-2016annualmeetingprox.htm DEF 14A 1234686
2 a02bfceligandpharmacommo001.jpg GRAPHIC 229336
3 a02bfceligandpharmacommo002.jpg GRAPHIC 102572
4 a02bffbligandpharmanotic001.jpg GRAPHIC 207587
5 a02bffbligandpharmanotic002.jpg GRAPHIC 168504
6 image0.jpg GRAPHIC 9775
7 image1a01.gif GRAPHIC 565
8 image2.gif GRAPHIC 1174
9 image3.gif GRAPHIC 612
10 image4.gif GRAPHIC 431
11 image5.jpg GRAPHIC 79797
  Complete submission text file 0000886163-16-000164.txt   2326048
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 161567293
SIC: 2834 Pharmaceutical Preparations